These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 21845053

  • 1. Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
    Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N.
    Ther Clin Risk Manag; 2011; 7():301-11. PubMed ID: 21845053
    [Abstract] [Full Text] [Related]

  • 2. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 3. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 16; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.
    Ivgy-May N, Hajak G, van Osta G, Braat S, Chang Q, Roth T.
    J Clin Sleep Med; 2020 Sep 15; 16(9):1455-1467. PubMed ID: 32351205
    [Abstract] [Full Text] [Related]

  • 10. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z.
    Arch Womens Ment Health; 2011 Jun 15; 14(3):269-73. PubMed ID: 21311927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
    Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L.
    Lancet Respir Med; 2019 Aug 15; 7(8):657-664. PubMed ID: 31122893
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder.
    Zisapel N.
    Expert Rev Clin Pharmacol; 2022 Feb 15; 15(2):175-185. PubMed ID: 35285365
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
    Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N.
    Diabetes Metab Syndr Obes; 2011 Feb 15; 4():307-13. PubMed ID: 21887103
    [Abstract] [Full Text] [Related]

  • 18. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 15; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin®) in insomnia].
    Quera-Salva MA, Claustrat B.
    Encephale; 2018 Dec 15; 44(6):548-557. PubMed ID: 30107892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.